President & CEO
Diane Tang-Liu, PhD, FAAPS, FCP, Co-Founder, President & Chief Executive Officer
Dr. Diane Tang-Liu is the Co-Founder, President, and Chief Executive Officer of AiViva BioPharma, a clinical-stage biotechnology firm specializing in innovative therapeutics for ophthalmology, dermatology, and oncology.
With over 35 years of leadership in the global pharmaceutical sector, Dr. Tang-Liu has overseen the entire spectrum of translational drug development through regulatory execution. Her experience includes building multidisciplinary R&D organizations and playing pivotal roles in the growth of biotechnology ventures. She possesses significant expertise in expediting drug development while maximizing long-term intellectual property value. Dr. Tang-Liu’s efforts have consistently merged scientific innovation with effective clinical strategies, enabling multiple products to reach commercialization. Before founding AiViva, she co-founded Allgenesis Biotherapeutics in Taiwan, and previously served as a senior executive at Allergan, where she led the development of novel therapies across several specialty areas.
Dr. Tang-Liu is an elected Fellow of the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacology. She has contributed to more than 80 peer-reviewed publications and holds over 80 patents as named inventor. Alongside her industry roles, she is a Full Adjunct Professor at the School of Pharmacy, University of Southern California, and at the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
Her accomplishments have been recognized with honors including the Vision in America Award from International Channel Network and being named one of the World’s Top 10 Outstanding Chinese Businesswoman Entrepreneurs by the Global Federation of Chinese Businesswomen. Dr. Tang-Liu holds a B.S. in Pharmacy from National Taiwan University and a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco.